Neurogene (NASDAQ:NGNE) Price Target Raised to $72.00 at Leerink Partners
Neurogene (NASDAQ:NGNE – Free Report) had its price target hoisted by Leerink Partners from $45.00 to $72.00 in a research report released on Tuesday,Benzinga reports. Leerink Partners currently has an outperform rating on the stock. Several other analysts also recently weighed in on the company. Robert W. Baird boosted their target price on Neurogene from […]
More Stories
Analysts’ Weekly Ratings Updates for Altair Engineering (ALTR)
Several analysts have recently updated their ratings and price targets for Altair Engineering (NASDAQ: ALTR): 11/3/2024 – Altair Engineering was...
MeadowBrook Investment Advisors LLC Sells 414 Shares of Duke Energy Co. (NYSE:DUK)
MeadowBrook Investment Advisors LLC cut its stake in shares of Duke Energy Co. (NYSE:DUK – Free Report) by 21.7% during...
Tokio Marine Asset Management Co. Ltd. Raises Holdings in Mastercard Incorporated (NYSE:MA)
Tokio Marine Asset Management Co. Ltd. boosted its stake in Mastercard Incorporated (NYSE:MA – Free Report) by 2.6% in the...
BioRestorative Therapies (NASDAQ:BRTX) Issues Quarterly Earnings Results
BioRestorative Therapies (NASDAQ:BRTX – Get Free Report) posted its quarterly earnings results on Tuesday. The company reported ($0.13) earnings per...
Metis Global Partners LLC Buys 649 Shares of Union Pacific Co. (NYSE:UNP)
Metis Global Partners LLC increased its holdings in Union Pacific Co. (NYSE:UNP – Free Report) by 2.5% in the third...
Extendicare (TSE:EXE) Price Target Raised to C$10.50
Extendicare (TSE:EXE – Get Free Report) had its price target boosted by TD Securities from C$9.50 to C$10.50 in a...